Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Enovis Corporation

Market Cap 1.22B 1.06B 972M 911M 1.7B 116B 1.74B 11.6B 4.49B 56.11B 4.56B 4.47B 195B P/E Ratio 2026 *
174x
P/E Ratio 2027 * 21.9x
Enterprise Value 2.42B 2.1B 1.94B 1.82B 3.4B 232B 3.47B 23.13B 8.96B 112B 9.1B 8.9B 389B EV / Sales 2026 *
1.03x
EV / Sales 2027 * 0.93x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-3.87%
1 week-7.61%
Current month-6.88%
1 month-14.77%
3 months-14.98%
6 months-24.08%
Current year-20.72%
1 week 20.55
Extreme 20.55
24.58
1 month 20.55
Extreme 20.55
26.66
Current year 20.55
Extreme 20.55
29.89
1 year 20.55
Extreme 20.55
36.82
3 years 20.55
Extreme 20.55
66.14
5 years 20.55
Extreme 20.55
164.01
10 years 20.55
Extreme 20.55
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Administrative Officer - 2026-01-04
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap.
05-31Buy

Chief Administrative Officer

1,000 0.0017%
05-18Free

Director

9,346 0.0164%
05-18Free

Director

9,346 0.0164%
Change 5-day change 1-year change 3-year change Capi.($)
-3.87%-7.61%-36.65%-63.13% 1.22B
-1.04%+1.47%-19.80%+8.91% 117B
+0.97%-0.04%+3.33%-3.25% 12.86B
+1.45%+2.11%+25.33%+84.50% 7.29B
-0.74%-5.28%-47.72%-69.62% 4.12B
-0.82%+3.46%+8.80%+30.33% 2.49B
+2.98%+4.59%-21.26%-19.19% 1.7B
-0.70%-7.93%+1.93%-12.89% 1.63B
+0.21%-1.92% - - 1.36B
Average -0.17%-1.09%-10.75%-5.54% 16.65B
Weighted average by Cap. -0.69%+1.06%-15.79%+8.60%

Financials

2026 *2027 *
Net sales 2.35B 2.04B 1.88B 1.76B 3.29B 225B 3.35B 22.39B 8.67B 108B 8.81B 8.62B 377B 2.47B 2.14B 1.98B 1.85B 3.46B 236B 3.53B 23.57B 9.12B 114B 9.27B 9.07B 396B
Net income 2.96M 2.57M 2.37M 2.22M 4.15M 283M 4.23M 28.24M 10.94M 137M 11.11M 10.87M 475M 54.22M 47.05M 43.37M 40.64M 75.93M 5.19B 77.51M 517M 200M 2.5B 204M 199M 8.7B
Net Debt 1.21B 1.05B 967M 906M 1.69B 116B 1.73B 11.53B 4.46B 55.78B 4.54B 4.44B 194B 1.08B 940M 867M 812M 1.52B 104B 1.55B 10.34B 4B 50.01B 4.07B 3.98B 174B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-06-11 21.12 $ -3.87% 1,502,441
26-06-10 21.97 $ -8.31% 1,514,967
26-06-09 23.96 $ +1.18% 979,245
26-06-08 23.68 $ -0.42% 694,147
26-06-05 23.78 $ +4.02% 709,587
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.12USD
Average target price
43.00USD
Spread / Average Target
+103.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!